Opioid Dependence & Suboxone

What Opioid Dependence Involves

Opioids — whether prescription painkillers, heroin, or fentanyl — act primarily at mu-opioid receptors, which are distributed throughout the brain and body and regulate pain, mood, stress response, and a range of vital autonomic functions. The brain's own opioid system, which normally operates through endogenous peptides like endorphins and enkephalins, is effectively overridden by exogenous opioids at doses far exceeding what the body produces naturally.

With sustained use, the brain adapts by downregulating mu-opioid receptor density and sensitivity — a process of receptor desensitization and internalization that reduces the system's responsiveness to stimulation. Endogenous opioid production simultaneously diminishes. The result is a nervous system that has reorganized itself around the continued presence of the drug to maintain anything resembling normal function. Physical dependence is the predictable consequence of this neuroadaptation, and it is distinct from addiction, though the two frequently coexist.

The HPA axis — the brain's central stress response system — becomes dysregulated during sustained opioid use and profoundly disrupted during withdrawal. Corticotropin-releasing factor activity surges, driving the anxiety, hyperalgesia, and dysphoria that characterize opioid withdrawal and that are among its most powerful reinforcers of continued use.

Withdrawal and Why It Matters

Opioid withdrawal is not typically life-threatening, but it is intensely destabilizing — physically and neurologically. The withdrawal syndrome reflects the abrupt unmasking of all the adaptations the nervous system made during dependence: autonomic hyperactivity, pain hypersensitivity, severe anxiety, insomnia, and a consuming psychological craving that is grounded in actual neurobiological need rather than mere desire.

Contrary to common understanding, the process of the brain returning to its own equilibrium after opioid dependence takes far longer than most people expect — well over a year in many cases, and longer with heavy or prolonged use. During that extended period, cognitive function, emotional regulation, and the capacity to tolerate distress are all impaired. Thinking clearly, functioning in daily life, and engaging in any kind of reflective work are genuinely difficult. This is the neurobiological reality that shapes everything about how treatment needs to be sequenced.

Suboxone and How I Use It

Suboxone (buprenorphine/naloxone) is a partial mu-opioid agonist with an exceptionally high binding affinity — it occupies opioid receptors more completely than full agonists and displaces them, while producing a ceiling effect that sharply limits its potential for respiratory depression and overdose. Because it has a long half-life and binds tightly without producing sharp peaks or crashes, it eliminates withdrawal, suppresses craving, and provides a stable neurological platform from which everything else becomes possible.

In my practice, Suboxone is a bridge and a tool — not a permanent destination. The taper is slow and deliberate, calibrated to the individual's clinical stability and the pace of the broader therapeutic work. Rapid tapering destabilizes the nervous system at exactly the moment when stability is most needed, and significantly increases the risk of relapse. A carefully managed taper, paced over the time the brain actually requires to readjust, leads to zero.

The Broader Treatment

Opioid dependence is almost always a response to something — physical pain, emotional pain, experiences that found no adequate outlet. The medication creates the neurological conditions for a person to think clearly and function. What follows is a serious ongoing conversation about what's underneath: the history, the logic of how someone arrived where they are, what has never felt possible to examine before.

This practice is not a prescribing service. The prescription and the conversation are part of the same treatment.

Frequently Asked Questions

Q: What is Suboxone and how does it work?

A: Suboxone (buprenorphine/naloxone) is a partial opioid agonist with an exceptionally high binding affinity. It occupies opioid receptors more completely than full agonists, eliminates withdrawal, suppresses craving, and provides a stable platform from which everything else in treatment becomes possible. It has a ceiling effect that sharply limits its potential for overdose.

Q: Is Suboxone just substituting one addiction for another?

A: No. Physical dependence and addiction are different things. Suboxone stabilizes the system so that a person can think clearly, function in daily life, and engage in the therapeutic work that addresses what was driving the opioid use. It is a treatment tool, not a destination.

Q: How long will I be on Suboxone?

A: The taper is slow and deliberate, calibrated to the individual's clinical stability and the pace of the broader therapeutic work. Returning to one's own equilibrium after opioid dependence takes considerably longer than most people expect — rapid tapering destabilizes the system at exactly the moment when stability is most needed.

Q: Can treatment be managed without anyone knowing?

A: Yes. The practice is entirely private with no office staff and no third-party involvement. Initial stabilization can be managed by phone and video, allowing most patients to continue working. Confidentiality is protected at every level.

Q: What if I have been using fentanyl?

A: The approach is the same as with any opioid. The initial transition to buprenorphine may be a little more complex, as fentanyl can accumulate in body fat in ways that affect the process. This is manageable and is taken into account from the start.

Q: Is treatment just about the medication?

A: No. Opioid dependence is almost always a response to something — physical pain, emotional pain, experiences that found no adequate outlet. The medication creates the conditions for a person to think clearly and function. What follows is a serious ongoing conversation about what is underneath. The prescription and the conversation are part of the same treatment.

Getting in Touch

The first conversation is free and completely confidential. There is no obligation of any kind.

Call directly: (646) 418-7077